Stirling Square Capital Partners has sold Vision Ophthalmology Group to AddLife AB, enhancing distribution capabilities in the European ophthalmic surgery market.

Information on the Target

Vision Ophthalmology Group (VOG) is recognized as a leading independent European distributor specializing in high-quality solutions for ophthalmic surgery. The company offers a comprehensive range of products and services tailored to eye surgeries, with a particular focus on cataract and glaucoma treatments. VOG has established itself as a key player in the market, known for its commitment to quality and innovation in ophthalmic healthcare.

Industry Overview in Sweden

Sweden boasts a robust healthcare system, which includes an advanced medical technology sector. The country is recognized for its strong emphasis on research and development, particularly in health-related fields. This focus has positioned Sweden as a leader in the European medical technology market, contributing significantly to innovation in healthcare solutions.

The ophthalmology segment, in particular, has seen substantial expansion due to increasing demand for eye care services driven by an aging population and rising prevalence of eye